Dubler, S.; Brenner, T.; Zimmermann, S.; Mokry, T.; Röhr, A.; Richter, D.C.; Heininger, A.; Weigand, M.A.
Off-Label Use of Ceftolozane/Tazobactam for the Successful Treatment of Healthcare-Associated Meningitis Caused by Extensively Drug-Resistant Pseudomonas aeruginosa in a Polytraumatized Patient—A Case Report. Reports 2022, 5, 33.
https://doi.org/10.3390/reports5030033
AMA Style
Dubler S, Brenner T, Zimmermann S, Mokry T, Röhr A, Richter DC, Heininger A, Weigand MA.
Off-Label Use of Ceftolozane/Tazobactam for the Successful Treatment of Healthcare-Associated Meningitis Caused by Extensively Drug-Resistant Pseudomonas aeruginosa in a Polytraumatized Patient—A Case Report. Reports. 2022; 5(3):33.
https://doi.org/10.3390/reports5030033
Chicago/Turabian Style
Dubler, Simon, Thorsten Brenner, Stefan Zimmermann, Theresa Mokry, Anka Röhr, Daniel C. Richter, Alexandra Heininger, and Markus A. Weigand.
2022. "Off-Label Use of Ceftolozane/Tazobactam for the Successful Treatment of Healthcare-Associated Meningitis Caused by Extensively Drug-Resistant Pseudomonas aeruginosa in a Polytraumatized Patient—A Case Report" Reports 5, no. 3: 33.
https://doi.org/10.3390/reports5030033
APA Style
Dubler, S., Brenner, T., Zimmermann, S., Mokry, T., Röhr, A., Richter, D. C., Heininger, A., & Weigand, M. A.
(2022). Off-Label Use of Ceftolozane/Tazobactam for the Successful Treatment of Healthcare-Associated Meningitis Caused by Extensively Drug-Resistant Pseudomonas aeruginosa in a Polytraumatized Patient—A Case Report. Reports, 5(3), 33.
https://doi.org/10.3390/reports5030033
